Colgate-Palmolive Q1 Earnings Beat Expectations, Full-Year Outlook Cut Due to Tariff Concerns.
ByAinvest
Sunday, Apr 27, 2025 3:12 pm ET1min read
CL--
Analysts remain positive on Colgate-Palmolive, with a one-year average price target of $97.81, suggesting a potential upside of 5.51% from the current price of $92.70 [1]. The company holds an "Outperform" consensus rating from 24 brokerage firms [1]. However, Colgate-Palmolive has lowered its full-year guidance due to tariff concerns and currency pressures, impacting its outlook for 2025. The company projects net sales to grow in low single digits, with a low-single-digit adverse impact of foreign exchange.
Shares of Colgate-Palmolive edged up to $95.25 but fell back, finishing down 2.18% for the quarter. Analysts have adjusted their price targets downward, reflecting the company's revised outlook. Colgate-Palmolive continues to invest in scaling its capabilities in key areas such as digital, data, and analytics to enhance competitive advantages and drive profitability [2].
References:
[1] https://www.gurufocus.com/news/2804441/colgatepalmolive-cl-surpasses-q1-earnings-expectations
[2] https://finance.yahoo.com/news/colgate-q1-earnings-sales-beat-164000952.html
Colgate-Palmolive reported Q1 results beating expectations, with net sales of $4.91 billion, a 3.1% decrease YoY, and organic sales growth of 1.4%. However, the company lowered its full-year guidance due to tariff concerns and currency pressures. Shares edged up to $95.25 but fell back, finishing down 2.18%. Analysts remain constructive on the stock but have adjusted their price targets downward.
Colgate-Palmolive (CL) reported its Q1 2025 earnings, beating market expectations with a Non-GAAP earnings per share (EPS) of $0.91, which exceeded estimates by $0.05 [1]. Despite a 3.1% decline in net sales to $4.91 billion, organic sales increased by 1.4% [2]. The company's earnings were driven by robust organic sales growth, volume, and pricing performance, as well as gross profit margin expansion. However, foreign exchange fluctuations negatively impacted total sales by 4.4%.Analysts remain positive on Colgate-Palmolive, with a one-year average price target of $97.81, suggesting a potential upside of 5.51% from the current price of $92.70 [1]. The company holds an "Outperform" consensus rating from 24 brokerage firms [1]. However, Colgate-Palmolive has lowered its full-year guidance due to tariff concerns and currency pressures, impacting its outlook for 2025. The company projects net sales to grow in low single digits, with a low-single-digit adverse impact of foreign exchange.
Shares of Colgate-Palmolive edged up to $95.25 but fell back, finishing down 2.18% for the quarter. Analysts have adjusted their price targets downward, reflecting the company's revised outlook. Colgate-Palmolive continues to invest in scaling its capabilities in key areas such as digital, data, and analytics to enhance competitive advantages and drive profitability [2].
References:
[1] https://www.gurufocus.com/news/2804441/colgatepalmolive-cl-surpasses-q1-earnings-expectations
[2] https://finance.yahoo.com/news/colgate-q1-earnings-sales-beat-164000952.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet